Atrial septal defect percutaneous closure benefits: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
{{ | {{Atrial septal defect}} | ||
{{CMG}} | {{CMG}}; Claudia Hochberg, M.D. | ||
'''Associate Editors-In-Chief:''' {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; [[Priyamvada Singh|Priyamvada Singh, MBBS]] [[mailto:psingh@perfuse.org]] | |||
'''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@perfuse.org]] | |||
==Overview== | |||
Among treatment options, percutaneous closure is the method of choice for ostium secundum patients. Many patients experience positive improvements in quality of life such as fewer compliations, shorter hospital stays, and overall symptomatic improvement. | |||
==Benefits of percutaneous closure== | ==Benefits of percutaneous closure== | ||
Percutaneous closure is the method of choice in most centers.<!-- | Percutaneous closure is the method of choice in most centers.<!-- | ||
--><ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref> Closure is associated with: | --><ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref> Closure is associated with: | ||
* Fewer complications | *Fewer complications | ||
*Shorter hospital stays | *Shorter hospital stays | ||
*Reduced need for blood transfusions | *Reduced need for blood transfusions | ||
| Line 23: | Line 30: | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Mature chapter]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 01:35, 27 July 2011
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect percutaneous closure benefits On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect percutaneous closure benefits | |
|
Atrial septal defect percutaneous closure benefits in the news | |
|
Risk calculators and risk factors for Atrial septal defect percutaneous closure benefits | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Claudia Hochberg, M.D.
Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3]; Priyamvada Singh, MBBS [[4]]
Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]
Overview
Among treatment options, percutaneous closure is the method of choice for ostium secundum patients. Many patients experience positive improvements in quality of life such as fewer compliations, shorter hospital stays, and overall symptomatic improvement.
Benefits of percutaneous closure
Percutaneous closure is the method of choice in most centers.[1] Closure is associated with:
- Fewer complications
- Shorter hospital stays
- Reduced need for blood transfusions
- Symptomatic improvement
- Regression of positive airway pressure
- Positive changes in right ventricle performance
- Improved functional capacity
- Improved left atrial volume index
- Improved left ventricular myocardial performance index
- Improved right ventricular myocardial performance index
- Improved peak oxygen uptake
References
- ↑ Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young. 16 (1): 3–10. PMID 16454871.